K.J. Harrison & Partners’s Coeptis Therapeutics Warrants COEPW Stock Holding History

K.J. Harrison & Partners’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,153	Closed	-$5K	–	336
2021 Q4	$5K	Hold	15,153	–	–	﹤0.01%	373
2021 Q3	$4K	Hold	15,153	–	–	﹤0.01%	381
2021 Q2	$8	Hold	15,153	–	–	﹤0.01%	355
2021 Q1	$7K	Buy	+15,153	New	+$14.2K	﹤0.01%	333

Other funds holding COEPW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

K.J. Harrison & Partners's COEPW Position: Q1 2022 in Review

K.J. Harrison & Partners sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2022, closing a stake of 15,153 shares — an estimated $5K sold.

K.J. Harrison & Partners first reported a position in COEPW in Q1 2021 and held it in 4 quarters. The position peaked at $7K in Q1 2021. 19 funds tracked by Wall St. Rank hold COEPW as of Q1 2022.

K.J. Harrison & Partners reported no remaining Coeptis Therapeutics Warrants position as of Q1 2022 after selling out during the quarter.
K.J. Harrison & Partners sold 15,153 Coeptis Therapeutics Warrants shares in Q1 2022, an estimated $5K.
K.J. Harrison & Partners first reported a position in Coeptis Therapeutics Warrants in Q1 2021 and held it in 4 quarters.
K.J. Harrison & Partners's Coeptis Therapeutics Warrants position peaked at $7K in Q1 2021.
19 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2022.

Based on K.J. Harrison & Partners's 13F filing for Q1 2022, filed 21 Apr 2022.